Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study
Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study
Recce Pharmaceuticals 從霧化 RECCE 327 試點研究中發現 “令人鼓舞” 的結果
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。